A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe drugs differently than their colleagues who do not. Further, the more money they receive, on average, the more brand-name medications they prescribe. Reporters matched records on payments from pharmaceutical and medical device makers in 2014 with corresponding data on doctors’ medication choices in Medicare’s prescription drug program in order to establish a trend. According to ProPublica, “doctors who got money from drug and device makers—even just a meal– prescribed a higher percentage of brand-name drugs overall [and] doctors who received industry payments were two to three times as likely to prescribe brand-name drugs at exceptionally high rates [compared to] others in their specialty.”
Read the full article via Workers’ Compensation 360 here.